Application 213233
- Type
- ANDA
- Sponsor
- DR REDDYS LABS SA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | TROCHE/LOZENGE;ORAL | EQ 2MG BASE | No | No |
| 002 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | TROCHE/LOZENGE;ORAL | EQ 4MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213233-001 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2020-08-04 | ||
| A213233-002 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2020-08-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213233-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2020-08-04 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213233-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2020-08-04 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Habitrol Lozenge Cherry | NICOTINE POLACRILEX | Dr. Reddy's Laboratories Inc. | 5a464242-7d63-141e-808e-c41676cf4b78 | 2026-07-09 | Warnings | 213233 ANDA213233 43598-985 43598-984 |
| Nicotine Polacrilex | NICOTINE POLACRILEX | Dr. Reddy's Laboratories Inc. | 6b0342dd-120f-a16e-098a-dc45b14d3d3a | 2026-07-09 | Warnings | 213233 ANDA213233 43598-488 43598-489 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 43598-488 | Nicotine Polacrilex | Nicotine Polacrilex | Dr. Reddy's Laboratories Inc. | ANDA | Current |
| 43598-489 | Nicotine Polacrilex | Nicotine Polacrilex | Dr. Reddy's Laboratories Inc. | ANDA | Current |
| 43598-984 | Habitrol Lozenge | Nicotine Polacrilex | Dr. Reddy's Laboratories Inc. | ANDA | Current |
| 43598-984 | Habitrol Lozenge | Nicotine Polacrilex | Dr. Reddy's Laboratories Inc. | ANDA | Current |
| 43598-985 | Habitrol Lozenge | Nicotine Polacrilex | Dr. Reddy's Laboratories Inc. | ANDA | Current |
| 43598-985 | Habitrol Lozenge | Nicotine Polacrilex | Dr. Reddy's Laboratories Inc. | ANDA | Current |